Myeloid cell tropism enables MHC-E–restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine
RhCMV/SIV vector tropism modulation differentially programs CD8+ T cell response MHC restriction and vaccine efficacy.
RhCMV/SIV vector tropism modulation differentially programs CD8+ T cell response MHC restriction and vaccine efficacy.